These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 21079048)

  • 1. MMP-2 mediates angiotensin II-induced hypertension under the transcriptional control of MMP-7 and TACE.
    Odenbach J; Wang X; Cooper S; Chow FL; Oka T; Lopaschuk G; Kassiri Z; Fernandez-Patron C
    Hypertension; 2011 Jan; 57(1):123-30. PubMed ID: 21079048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor necrosis factor-alpha-converting enzyme is a key regulator of agonist-induced cardiac hypertrophy and fibrosis.
    Wang X; Oka T; Chow FL; Cooper SB; Odenbach J; Lopaschuk GD; Kassiri Z; Fernandez-Patron C
    Hypertension; 2009 Sep; 54(3):575-82. PubMed ID: 19581512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinase-7 and ADAM-12 (a disintegrin and metalloproteinase-12) define a signaling axis in agonist-induced hypertension and cardiac hypertrophy.
    Wang X; Chow FL; Oka T; Hao L; Lopez-Campistrous A; Kelly S; Cooper S; Odenbach J; Finegan BA; Schulz R; Kassiri Z; Lopaschuk GD; Fernandez-Patron C
    Circulation; 2009 May; 119(18):2480-9. PubMed ID: 19398663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor necrosis factor-alpha--converting enzyme roles in hypertension-induced hypertrophy: look both ways when crossing the street.
    Zamilpa R; Chilton RJ; Lindsey ML
    Hypertension; 2009 Sep; 54(3):471-2. PubMed ID: 19581499
    [No Abstract]   [Full Text] [Related]  

  • 5. Upregulation of Nox4 promotes angiotensin II-induced epidermal growth factor receptor activation and subsequent cardiac hypertrophy by increasing ADAM17 expression.
    Zeng SY; Chen X; Chen SR; Li Q; Wang YH; Zou J; Cao WW; Luo JN; Gao H; Liu PQ
    Can J Cardiol; 2013 Oct; 29(10):1310-9. PubMed ID: 23850346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights into the activity, differential expression, mutual regulation, and functions of matrix metalloproteinases and a disintegrin and metalloproteinases in hypertension and cardiac disease.
    Berry E; Bosonea AM; Wang X; Fernandez-Patron C
    J Vasc Res; 2013; 50(1):52-68. PubMed ID: 23172306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular ADAM17 as a Novel Therapeutic Target in Mediating Cardiovascular Hypertrophy and Perivascular Fibrosis Induced by Angiotensin II.
    Takayanagi T; Forrester SJ; Kawai T; Obama T; Tsuji T; Elliott KJ; Nuti E; Rossello A; Kwok HF; Scalia R; Rizzo V; Eguchi S
    Hypertension; 2016 Oct; 68(4):949-955. PubMed ID: 27480833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted deletion of matrix metalloproteinase 2 ameliorates myocardial remodeling in mice with chronic pressure overload.
    Matsusaka H; Ide T; Matsushima S; Ikeuchi M; Kubota T; Sunagawa K; Kinugawa S; Tsutsui H
    Hypertension; 2006 Apr; 47(4):711-7. PubMed ID: 16505197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II induced proteolytic cleavage of myocardial ACE2 is mediated by TACE/ADAM-17: a positive feedback mechanism in the RAS.
    Patel VB; Clarke N; Wang Z; Fan D; Parajuli N; Basu R; Putko B; Kassiri Z; Turner AJ; Oudit GY
    J Mol Cell Cardiol; 2014 Jan; 66():167-76. PubMed ID: 24332999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Copper-induced reduction in myocardial fibrosis is associated with increased matrix metalloproteins in a rat model of cardiac hypertrophy.
    Liu Y; Xiao Y; Liu J; Feng L; Kang YJ
    Metallomics; 2018 Jan; 10(1):201-208. PubMed ID: 29302675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DKK3 overexpression attenuates cardiac hypertrophy and fibrosis in an angiotensin-perfused animal model by regulating the ADAM17/ACE2 and GSK-3β/β-catenin pathways.
    Zhai CG; Xu YY; Tie YY; Zhang Y; Chen WQ; Ji XP; Mao Y; Qiao L; Cheng J; Xu QB; Zhang C
    J Mol Cell Cardiol; 2018 Jan; 114():243-252. PubMed ID: 29196099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-(1-7) ameliorates myocardial remodeling and interstitial fibrosis in spontaneous hypertension: role of MMPs/TIMPs.
    Pei Z; Meng R; Li G; Yan G; Xu C; Zhuang Z; Ren J; Wu Z
    Toxicol Lett; 2010 Nov; 199(2):173-81. PubMed ID: 20837116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of epidermal growth factor receptor and endoplasmic reticulum stress in vascular remodeling induced by angiotensin II.
    Takayanagi T; Kawai T; Forrester SJ; Obama T; Tsuji T; Fukuda Y; Elliott KJ; Tilley DG; Davisson RL; Park JY; Eguchi S
    Hypertension; 2015 Jun; 65(6):1349-55. PubMed ID: 25916723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinase-2 mediates a mechanism of metabolic cardioprotection consisting of negative regulation of the sterol regulatory element-binding protein-2/3-hydroxy-3-methylglutaryl-CoA reductase pathway in the heart.
    Wang X; Berry E; Hernandez-Anzaldo S; Takawale A; Kassiri Z; Fernandez-Patron C
    Hypertension; 2015 Apr; 65(4):882-8. PubMed ID: 25646300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction.
    Zhong J; Basu R; Guo D; Chow FL; Byrns S; Schuster M; Loibner H; Wang XH; Penninger JM; Kassiri Z; Oudit GY
    Circulation; 2010 Aug; 122(7):717-28, 18 p following 728. PubMed ID: 20679547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycosylated CD147 reduces myocardial collagen cross-linking in cardiac hypertrophy.
    Ru NY; Cui LB; Jiao B; Zhang L; Jiang S; Yu ZB
    J Cell Biochem; 2018 Nov; 119(10):8022-8034. PubMed ID: 29377254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Rho-kinase by fasudil attenuated angiotensin II-induced cardiac hypertrophy in apolipoprotein E deficient mice.
    Wang YX; da Cunha V; Martin-McNulty B; Vincelette J; Li W; Choy DF; Halks-Miller M; Mahmoudi M; Schroeder M; Johns A; Light DR; Dole WP
    Eur J Pharmacol; 2005 Apr; 512(2-3):215-22. PubMed ID: 15840407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac-deleterious role of galectin-3 in chronic angiotensin II-induced hypertension.
    González GE; Rhaleb NE; D'Ambrosio MA; Nakagawa P; Liao TD; Peterson EL; Leung P; Dai X; Janic B; Liu YH; Yang XP; Carretero OA
    Am J Physiol Heart Circ Physiol; 2016 Nov; 311(5):H1287-H1296. PubMed ID: 27496875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BMP type I receptor ALK2 is required for angiotensin II-induced cardiac hypertrophy.
    Shahid M; Spagnolli E; Ernande L; Thoonen R; Kolodziej SA; Leyton PA; Cheng J; Tainsh RE; Mayeur C; Rhee DK; Wu MX; Scherrer-Crosbie M; Buys ES; Zapol WM; Bloch KD; Bloch DB
    Am J Physiol Heart Circ Physiol; 2016 Apr; 310(8):H984-94. PubMed ID: 26873969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential hypertensive protease expression in the thoracic versus abdominal aorta.
    Ruddy JM; Akerman AW; Kimbrough D; Nadeau EK; Stroud RE; Mukherjee R; Ikonomidis JS; Jones JA
    J Vasc Surg; 2017 Nov; 66(5):1543-1552. PubMed ID: 28034583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.